ABSTRACT: Introduction: A method for quantifying myofiber size noninvasively would find wide use, including primary diagnosis and evaluating response to therapy. Methods: Using prediction algorithms, including the least absolute shrinkage and selection operator, we applied multifrequency electrical impedance myography (EIM) to amyotrophic lateral sclerosis superoxide dismutase 1 G93A mice of different ages and assessed myofiber size histologically. Results: Multifrequency EIM data provided highly accurate predictions of myofiber size, with a root mean squared error (RMSE) of only 14% in mean myofiber area (corresponding to ± 207 μm 2 for a mean area of 1,488 μm 2 ) and an RMSE of only 8.8% in predicting the coefficient of variation in fiber size distribution. Discussion: This impedance-based approach provides predictive variables to assess myofiber size and distribution with good accuracy, particularly in diseases in which myofiber atrophy is the predominant histological feature, without the requirement for biopsy or burdensome quantification.
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Although each of these types of atrophy is distinctly different, they all share the common feature of representing some form of pathological alteration of tissue. Currently, assessing such muscle pathology is not possible without performing a biopsy and removing a piece of tissue for microscopic analysis. Although standard radiological and electrophysiological techniques are not capable of assessing myofiber size, one technique that holds promise for this specific use is electrical impedance myography (EIM). In EIM, a weak electrical current is applied to a region of muscle, and the consequent voltages are measured from a second set of electrodes. 2 The alterations in the recorded voltages, including changes in the amplitude of the voltage and the timing relative to the applied current, are closely related to the compositional and morphological characteristics of the tissue.
Recently, we evaluated the prospect of using EIM specifically for the assessment of myofiber size by evaluating a group of wild-type mice of varying age from postnatal day 5 to postnatal day 35, a period of dramatic myofiber growth. 3 Using 4 needle electrodes to obtain multifrequency EIM measurements and a standard multiple regression prediction technique termed least absolute shrinkage and selection operator (LASSO), 4 we were able to predict myofiber size with errors as low as 12% from the impedance data and the age of the animal alone.
In this study we sought to advance this approach by evaluating pathological tissue, performing the measurements with surface rather than needle electrodes, and using EIM parameters alone in the regression equation. To do so, we performed EIM on a cohort of amyotrophic lateral sclerosis (ALS) superoxide dismutase 1 (SOD1) G93A mice 5 of various ages and then humanely killed the animals to evaluate quantitative histopathology, with the goal of determining how precisely we could predict myofiber size in this disease model. If it ultimately is successful, this basic EIM approach could be used for quantifying the degree of fiber atrophy and approximating mean myofiber size and the degree of denervation in a given muscle in patient with a variety of neuromuscular disorders.
MATERIALS AND METHODS
Mice. Beth Israel Deaconess Institutional Animal Care and Use Committee approval was obtained prior to the initiation of any studies. Breeding pairs of ALS B6SJL-Tg(SOD1-G93A) 1Gur/J mice were obtained from Jackson Laboratories (Bar Harbor, ME, USA) and bred to obtain 37 animals (approximately half female and half male). To study varying fiber size, animals were humanely killed at various ages ranging from 8-18 weeks (approximately 6-7 animals per fortnight, at 8, 10, 12, 14, 16, and 18 weeks).
Electrical Impedance Myography. Surface impedance measurements were performed under 1%-2% inhaled isoflurane anesthesia delivered by nose cone, with body and muscle temperature being maintained at 37 C by a heating pad, as previously described. 6 After removing the fur with clippers, a depilatory agent was applied to the left hind limb to eliminate any remaining fur, and the skin was cleaned with 0.9% saline solution. The animal was placed in a prone position, and both legs were taped to the measuring surface at an approximately 45 angle extending out from the body in preparation for measurements. A fixed rigid 4-electrode impedancemeasuring surface array was applied over the left gastrocnemius muscle. EIM measurements were performed with the mView system (Myolex, San Francisco, CA, USA), which obtains impedance data at 41 frequencies from 1 kHZ to 10 MHZ, as previously described. 6, 7 For this analysis, we removed data from all frequencies below 20 kHZ and above 7.5 MHZ because they often were impacted by contact artifact and inductive affects, respectively, and only added noise to the overall impedance spectrum, yielding EIM data for 34 frequencies. Data were first collected with electrical current flow passed parallel (longitudinal) to the muscle fibers and then, after rotating the electrode array 90
, perpendicular to the muscle fibers (transverse).
Histological Analysis. After EIM measurements were completed, the left gastrocnemius was excised and fixed in 10% formalin. The tissue was then embedded in paraffin and sectioned into 10-μm slices. Sections were stained with collagen VI antibodies (No. 6588; Abcam, Cambridge, MA, USA) to identify the cell membrane and with 4 0 ,6-diamidino-2-phenylindole to stain nuclei. Individual sections were viewed and photographed with an Axio Imager M1 (Zeiss, Oberkochen, Germany) epifluorescence microscope. Myofiber area was identified in Volocity software (Perkin Elmer, Waltham, MA, USA) by using the automated algorithms that identify the fiber membranes and counts completed. On average, approximately 250 fibers were counted per muscle. Careful attention was paid to measure all cells that appeared to be myofibers, with the goal of measuring representative fields that accurately reflected the overall status of the muscle.
Data Analysis. EIM data outputs included the resistance, reactance, and phase values at 34 frequencies in both the longitudinal and transverse directions (a total of approximately 204 outputs per animal). Prior to beginning the formal data analysis, we reviewed all EIM traces, removed any errant individual frequency points, and performed a simple imputation technique in which the results for the frequency immediately below and above were averaged and substituted for the value obtained.
We followed an approach analogous to that previously used. 3 Briefly, we first standardized the mean muscle fiber size and the impedance parameters to unit normal scale to remove the effect of the underlying unit of measurement. We then employed LASSO for assessing the entire multifrequency (resistance, reactance, and phase) components measures along the longitudinal and transverse directions without imposing any a priori structure on them. The LASSO approach, which includes a penalty on the coefficients of the parameters, assumes that very few components of the multifrequency relate to the myofiber size. This assumption is essential because the number of components in the multifrequency set is much larger than the sample size in our study. The penalty, defined as the absolute sum of the predictors' coefficients weighted by the tuning parameter, "shrinks" coefficients of the predictors that play very little role in explaining the response variability and thereby "selects" the predictors that are strongly associated with the outcome. In this study, the penalty parameter in our model was selected by using the leave-one-out cross-validation (LOOCV) approach. As a first step, a grid of values is specified for the penalty term in the above LOOCV procedure. We then split the sample into 2 sets, a validation set and a training set. For a specific value of the penalty term, we build the model on the training set and then test its predictive performance (squared residual) on the observation that is in the validation set. As the name of LOOCV implies, we include only 1 random sample in the validation set while retaining the remaining observations in the training set. We repeat the above steps on the entire set of observations to obtain the average of residual square (which is an estimate of mean square error) for this particular value of the penalty term. The final penalty value is chosen to be one that provides a minimum mean square error on the entire grid of penalty. As a last step, the model is fit on the entire data for the final chosen value of penalty term to obtain the estimates of model parameters. The predictive models that are developed by using the LASSO approach (with cross-validation) tend to have biased estimates of the parameters. However, these estimates also have relatively low variability in comparison to alternate models and, hence, perform extremely well in the out-of-sample datasets. 8 
RESULTS
Among the total number of mice originally studied (N = 37), 8 animals were excluded in their entirety because EIM data from these mice were markedly distorted by artifact across the entire frequency range in a single direction (i.e., transverse or longitudinal), as determined by visual inspection of reactance versus resistance curves. This included negative values at either high or low frequencies, values far outside the expected range (e.g., reactance values of greater than 200 ohm), or a nonphysiological impedance spectrum (e.g., a single major reactance peak at 1 MHZ rather than a peak at approximately 100 kHZ and second upward trend above 1 MHZ). In addition, 7 of 19 animals (19% of data points) had missing or egregious impedance data points at specific single frequencies. For these animals, data (14 values from a total of 5,916 collected) were imputed as described above. This resulted in complete data sets from a total of 29 ALS animals from 8-18 weeks of age that were used in our analysis. Figure 1 shows the basic longitudinal EIM data set obtained from female mice at 8, 12, and 16 weeks of age, including representative histological images, the impedance (i.e., reactance and resistance) versus frequency plots, and the Nyquist (reactance vs. resistance) plots at each time point. With increasing age, and therefore with increasing disease severity, there is a gradual alteration in the impedance spectra that is most easily observed in the Nyquist plots. Similar histological findings and impedance data were observed for the male ALS mice studied from 8-18 weeks (data not shown).
Our predictive model (which is based on the combined data sets from both female and male mice) using the LASSO strategy and relying on EIM frequencies alone gave an approximate root mean square error (RMSE) of 14% (or 207 μm 2 ) for a mean fiber area of 1,488 μm 2 . Figure 2A shows the actual LASSO regression, comparing the predicted values (abscissa) to the actual values (ordinate) across these animals. A combination of longitudinal and transverse EIM data from only 10 frequency components was required to perform the prediction for either mean fiber size or coefficient of variation (CoV).
A major anticipated change of ALS-impacted muscle is the development of denervation atrophynamely, group atrophy with some fibers remaining normal size and others substantially reduced in size often, in patchy fashion. Such a mixed-size fiber population would increases the CoV (i.e., the standard deviation of fiber size/mean of fiber size) of the fiber size; the greater the variation in the fiber size, the greater the CoV. Indeed, a similar prediction model predicted the CoV. The results of this analysis are shown in Figure 2B , with a RMSE of only 8.8%. Supporting Information Table 1 provides the exact frequencies derived from the corresponding prediction models that were used to calculate the mean fiber area and the CoV.
DISCUSSION
We have demonstrated that by using noninvasive surface-based EIM and a prediction model it is possible to achieve a reasonable estimate of the degree of myofiber size and variation in muscle impacted by ALS, including the degree of relative atrophy in the muscle and the distribution of myofiber sizes.
Previous work in ALS has evaluated EIM in comparison to standard electrophysiological parameters, including the motor unit number estimate (MUNE) and the compound motor action potential (CMAP) amplitude. 9, 10 Those studies identified a strong relationship between EIM and these parameters. In addition, we have evaluated the relationship between EIM and force output in ALS mice and again found a robust relationship. 11 It is perhaps not unexpected, therefore, that we identified a similar relationship between EIM and muscle fiber size here. The novelty of this work compared with those earlier studies is that, in the present analysis, we sought to identify a predictive model-in other words, we used raw impedance data alone to predict myofiber size rather than simply establishing a correlation between the EIM parameters and the electrophysiological/functional parameters. Also, we generated the predictive model using the entire frequency set and the predictive LASSO approach rather than basing our analysis on just a single frequency or subset of frequencies (as has been the case for most studies). The value of this approach is that anyone using the same methodologies that we performed here can use the coefficients derived in this prediction equation to approximate myofiber size in their sample, provided that the same electrode array is used and frequencies are measured. In some respects, myofiber atrophy in ALS is a secondary effect-it is, after all, merely a downstream result of motor neuron loss. Nevertheless, having a tool to quantify noninvasively myofiber size and distribution could serve a variety of purposes in ALS research. First, it could provide a means for assessing the effect of therapies geared specifically to impacting muscle health, which remains very much a possibility, either as a primary or as secondary/adjuvant therapy. 12 In addition, it is possible that this data set could be used in conjunction with standard measures, such as CMAP and MUNE, to provide a broader sense of end organ health and effects of therapy in this disease.
More broadly, this study demonstrates that the technology and this approach have the potential to be used in other neuromuscular disorders with substantial fiber atrophy. One of our reasons for choosing to study specifically ALS animals is that they tend to develop only fiber atrophy with little other significant intramuscular pathology. Under other conditions in which there is primary myofiber atrophy with little other accompanying interstitial change (e.g., disuse, sarcopenia, and corticosteroid use), this same approach can be similarly used. However, it may also be possible to use this approach even when there are additional superimposed pathological features in the muscle tissue (e.g., connective tissue deposition or intracellular abnormalities), although this has yet to be determined and remains the goal of further study.
It is worth considering the mechanisms of fiber atrophy in ALS. Although some fibers may be normal and entirely unaffected and others are severely atrophied, likely related to complete denervation, histopathological analysis revealed that in the ALS animals many fibers were actually smaller than normal but not severely atrophied. There are several possible reasons for this, including the presence of recently denervated fibers (i.e., those in the process of shrinking), recently reinnervated fibers (i.e., those in the process of growing), and reduced leg use producing secondary disuse atrophy.
Compared to our previous study that adopted an EIM-based predictive approach, 3 there were several major differences here. First, in the previous study, we used needle electrodes placed in only 1 direction (longitudinally). The reason for that decision was mostly practical because the hind limbs in the early postnatal mice were too small to accommodate a surface electrode array or to perform transverse measurements. However, by doing so, we also removed 1 potential confounding factor, the skin and subcutaneous fat, which contribute to some of the previously described artifact-related challenges. In addition, the skin and fat will impact the data set to at least some extent, 13 likely somewhat weakening the technique's predictive capability, especially if those tissues alter during the disease course along with the myofiber atrophy. Second, because the animals in the previous study were all healthy, they had a normal fiber size distribution; in other words, the CoV in fiber size was identical across all postnatal ages examined. In the ALS animals studied here, there was considerable variation in the distribution of fiber size, with some preserved fibers, some already quite atrophied, and others in between. This range in pathology is reflected in the distribution of the CoV that we observed. Therefore, we would not expect the same frequencies to be identified as relevant predictors. Nevertheless, 4 of the 14 parameters in that study were used here (428 kHZ reactance, 1,027 kHZ resistance and phase, and 5,915 kHZ phase).
There are several limitations to this study, the most important of which is that we did not employ a completely separate test group but rather used the approach of multiple sampling with crossvalidation from the same group. Analysis of a separate test group is challenging to achieve because of the large number of animals that would be required. Nevertheless we did perform a more basic k-fold cross-validation approach 14 (splitting the set into smaller groups and using 1 group for training and 1 group for validation) and found that it gave us similar results. However, our LOOCV approach is more appropriate for this small data set because it helps to ensure that the prediction model developed here does not over fit the observed outcome. A second limitation is that we were forced to remove 22% (i.e., 8/37) of animals from the original data set because of poor EIM data quality. Improved approaches for evaluating data quality at the time of collection are now underway such that artifacts impacting data can be avoided. One possibility would be to produce an automated algorithm that can help screen and remove such data prior to analysis; this is currently in development. Doing so would help reduce any bias that may occur when doing so by simple visual inspection, as we have done here. Finally, although the critical EIM parameters identified in these prediction models are valid for the ALS mouse, they could not be applied directly to humans without actually developing a separate model that would once again require correlation of EIM values with histological data. Therefore, this methodology would likely be best limited to preclinical research in which longitudinal assessments on animals are being performed, and killing of the animals is to be avoided. In summary, we have shown that the surface based technique of EIM in conjunction with a prediction algorithm can effectively predict myofiber size noninvasively in an ALS mouse model. Additional study of this approach in ALS research and in additional animal models of neuromuscular disease may provide additional insights regarding how this approach can be used most effectively. This will also include the use of dedicated EIM needle electrodes or combined EIM/electromyography electrodes such that morphological and compositional data can be acquired along with standard electrophysiological measures. 15 Our laboratory also plans to continue this work by determining the capability of the EIM technology to assess other compositional alterations of the muscle tissue, including the presence of both extracellular and intracellular pathologies.
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